K

Kolon Life Science Inc
KOSDAQ:102940

Watchlist Manager
Kolon Life Science Inc
KOSDAQ:102940
Watchlist
Price: 46 150 KRW -2.43% Market Closed
Market Cap: 573.2B KRW

Kolon Life Science Inc
Operating Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Kolon Life Science Inc
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
K
Kolon Life Science Inc
KOSDAQ:102940
Operating Income
-â‚©10.9B
CAGR 3-Years
N/A
CAGR 5-Years
11%
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Operating Income
â‚©92B
CAGR 3-Years
39%
CAGR 5-Years
25%
CAGR 10-Years
1%
SK Biopharmaceuticals Co Ltd
KRX:326030
Operating Income
â‚©147.6B
CAGR 3-Years
178%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Operating Income
â‚©200.9B
CAGR 3-Years
10%
CAGR 5-Years
17%
CAGR 10-Years
35%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Operating Income
-â‚©1.8B
CAGR 3-Years
15%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Caregen Co Ltd
KOSDAQ:214370
Operating Income
â‚©36.4B
CAGR 3-Years
7%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
No Stocks Found

Kolon Life Science Inc
Glance View

Market Cap
573.3B KRW
Industry
Pharmaceuticals

KOLON Life Science, Inc. engages in the manufacture and sale of pharmaceuticals and environment materials. The company is headquartered in Seoul, Seoul and currently employs 451 full-time employees. The company went IPO on 2009-04-07. The firm operates its business under two segments. The Chemical Business segment produces and sells raw drug products, which are the raw materials of new drugs and generic drugs, antibacterial agents that suppress bacterial growth, water treatment agents for environmental purification, and functional material products for cosmetics. The Bio Business segment manufactures and sells bio new medicines based on cell gene therapy products.

Intrinsic Value
24 867.79 KRW
Overvaluation 46%
Intrinsic Value
Price
K

See Also

What is Kolon Life Science Inc's Operating Income?
Operating Income
-10.9B KRW

Based on the financial report for Jun 30, 2025, Kolon Life Science Inc's Operating Income amounts to -10.9B KRW.

What is Kolon Life Science Inc's Operating Income growth rate?
Operating Income CAGR 5Y
11%

Over the last year, the Operating Income growth was 54%.

Back to Top